A Data Monitoring Committee (DMC) is a group of clinicians and biostatisticians appointed by the study Sponsor who provide independent assessment of the safety, scientific validity and integrity of a clinical trial while it is ongoing.
DMCs are strongly recommended by Regulatory Authorities in all trials that assess new interventions but also trials that can have safety issues and/or double blind/double mask treatment assignment. The main objective of these DMCs is to protect the patient.
DMC member contracting | Programming |
Presentation of results at open and closed meeting | Data quality review |
DMC organization including logistics | Blinded or unblinded analyses |
Charter design and/or review | TFLs for interim analyses |
Safety and interim efficacy analyses | Reports |
Design of templates | Presentation of results at open and closed meeting |
Data Transfers |
Almustat dedicates a portion of its biostatistics team to IDMC support: (experienced biostatisticians serving as independent statisticians, experts serving as DMC Members).
Our biostatisticians are true experts, delivering only what the committee members need in a succinct, complete and reproducible fashion.
Our years of experience supporting multiple DMCs have positioned us to develop a clear, precise report format that enables swift and thorough review of reports by DMC members.
Thanks to their extensive experience in DMCs, IDDI biostatisticians are highly knowledgeable about relevant statistical methods associated with interim analyses, including sequential designs, group-sequential designs, adaptive designs, conditional power and futility calculations, and sample-size adjustments.
Getting an accurate diagnosis can be one of the most impactful experiences that you can have.
Copyright © 2024 Almustat.com